Dermatoscopic evolution of dysplastic nevi showing high-grade dysplasia in a metastatic melanoma patient on vemurafenib - 14/11/12
Doi : 10.1016/j.jaad.2012.05.031
Pedram Gerami, MD a, b, ⁎ 
, Jennifer Sorrell, MD a, Mary Martini, MD a, b
, Jennifer Sorrell, MD a, Mary Martini, MD a, b a Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
b Robert H. Lurie Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
Correspondence to: Pedram Gerami, MD, Northwestern University, Department of Dermatology and the Robert H. Lurie Cancer Center, 676 N St Clair Street, Suite 1600, Chicago, IL 60611| Disclosure: Dr Gerami has served as a consultant to Abbott Molecular Labs and Neogenomics and has received honoraria for this. This work was supported by the Dermatology Foundation and the American Cancer Society, IL Division (Sponsored Reference Award#: 160272). Dr Martini has served on the advisory board of Dove-Unilever and has received honoraria for this. She has also been an investigator for Melasciences Inc. |
|
| Conflicts of interest: None declared. |
© 2012
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 67 - N° 6
P. e275-e276 - décembre 2012 Retour au numéro
Article précédent
- Drug-induced subacute cutaneous lupus erythematosus associated with doxorubicin
- Jennifer K. Chen, Tina S. Chen, Pearlie Lim, Marvi Iqbal
- Sialoblastoma: An unexpected diagnosis
- Megan M. Brown, Erica J. Walsh, Anil Shetty, Aimee C. Smidt
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?